Share: Facebook Twitter LinkedIn
Activity Provided By:

Physicians’ Education Resource®, LLC

Virtual Case Studies™ in Chronic Kidney Disease: Optimizing Patient Selection When Considering Non-Steroidal Mineralocorticoid Receptor Antagonists

Access Activity

Overview / Abstract:

Target Audience
This program is intended for Nephrologists, Primary Care Physicians, Endocrinologists, Cardiologists, and Physician Assistants/Nurse Practitioners.

Program Overview
Chronic kidney disease (CKD) is a disease multiplier that increases the risk of stroke and other cardiovascular diseases. Patients with CKD and diabetes have a high risk of complications, including diabetic retinopathy, diabetic foot, anemia, metabolic bone disease, fracture, infection, and neuropathy. Patients given a diagnosis of CKD also have a greater risk of iatrogenic injury from drug therapy, including acute kidney injury, hypoglycemia, and hyperkalemia. Affected patients also have high rates of comorbidities, such as depression and heart failure. Not surprisingly, this burden of complications and comorbidity translates to poor quality of life and substantially higher use of health care resources and associated costs.

This online activity is designed to promote clinical decision-making via virtual case simulations and expert faculty commentary. Clinicians are presented with 2 patient case simulations; each is followed by a panel discussion that addresses main clinical points related to the simulations. In addition, members of the faculty discuss strategies for renal and cardiovascular protection and the importance of multidisciplinary care for patients with CKD.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Incorporate guideline recommended criteria/testing procedures for the diagnosis of DKD
Analyze the role of pathophysiologic mechanism of DKD in the progression of cardiorenal dysfunction
Develop individualized treatment plans incorporating non-glucose lowering therapies for patients with DKD
Identify patient risk factors for developing hyperkalemia with non-glucose lowering therapies

Expiration

Oct 14, 2022

Discipline(s)

Nursing CNE, Physician CME

Format

Online

Credits / Hours

1.75

Accreditation

ACCME, ANCC

Presenters / Authors / Faculty

George Bakris, MD
Jon W. Mares
Biff F. Palmer
Ileana L Piña

Sponsors / Supporters / Grant Providers

Bayer Healthcare Pharmaceuticals Inc.

Keywords / Search Terms

Relias LLC Relias LLC Relias, Free CME, Chronic Kidney Disease Free CE CME, CKD Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map